Yoshiyuki Wada

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Gut · 2019 · 723 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan et al. · Cancers · 2019 · 298 citations · Full text

Medicine, Oncology, Surgery +14

Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of Vater

Wataru Kimura, Noriaki Futakawa, Seiichi YAMAGATA et al. · Japanese Journal of Cancer Research · 1994 · 256 citations

Medicine, Oncology, Pathology +16

REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

Tatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda et al. · Journal of Gastroenterology · 2019 · 227 citations · Full text

Medicine, Oncology, Pharmacotherapy +13